Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial

Peer Review reports

Original Submission
4 Apr 2022	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
6 May 2022	Reviewed	Reviewer Report
27 May 2022	Reviewed	Reviewer Report - Bianca Mostert
13 Jun 2022	Author responded	Author comments - Edward Yu
Resubmission - Version 3
13 Jun 2022	Submitted	Manuscript version 3
16 Jun 2022	Reviewed	Reviewer Report - Bianca Mostert
20 Jun 2022	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
30 Jun 2022	Editorially accepted
8 Jul 2022	Article published	10.1186/s12885-022-09846-0

Back to article page